We are live on ! Find out more
LA

Lau Associates Portfolio holdings

AUM $201M
1-Year Est. Return 26.29%
This Fund
S&P 500
This Quarter Est. Return
+6.78%
1 Year Est. Return
+26.29%
3 Year Est. Return
+44.49%
5 Year Est. Return
+59.98%
10 Year Est. Return
AUM
$129M
AUM Growth
-$264K
Cap. Flow
-$7.57M
Cap. Flow %
-5.89%
Top 10 Hldgs %
48.17%
Holding
81
New
6
Increased
22
Reduced
25
Closed
4

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$2.75M
2
MRK icon
Merck
MRK
+$2.17M
3
QCOM icon
Qualcomm
QCOM
+$1.26M
4
NWL icon
Newell Brands
NWL
+$1.15M
5
F icon
Ford
F
+$875K

Sector Composition

Rank Sector Weight
1 Technology 21.05%
2 Healthcare 16.98%
3 Consumer Staples 12.33%
4 Energy 10.14%
5 Industrials 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGI
76
DELISTED
Celadon Group Inc
CGI
$128K 0.1%
20,000
ACGN
77
DELISTED
Aceragen Inc
ACGN
$38K 0.03%
133
GILD icon
78
Gilead Sciences
GILD
$165B
-34,000
Closed -$2.75M
NWL icon
79
Newell Brands
NWL
$2.18B
-26,900
Closed -$1.15M
QCOM icon
80
Qualcomm
QCOM
$180B
-24,277
Closed -$1.26M
VCSH icon
81
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
-7,700
Closed -$617K

Similar funds

Lau Associates's Q4 2017 Portfolio in Review

As of Q4 2017, Lau Associates held 81 positions worth $129M, down 0.2% from $129M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Lau Associates withdrew a net $7.57M in Q4 2017, closing 4 positions and reducing 25 holdings. Its most notable exit was Gilead Sciences, an estimated $2.75M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Lau Associates opened a new position in Cummins worth $1.54M.

  • Lau Associates's largest Q4 2017 buy was Cummins: 8,700 shares worth $1.54M.
  • Lau Associates added most to Alaska Air in Q4 2017, an estimated $757K increase.
  • Lau Associates's biggest Q4 2017 reduction was Merck, cutting an estimated $2.17M.
  • Lau Associates fully exited Gilead Sciences in Q4 2017, selling an estimated $2.75M.
  • Lau Associates's ten largest holdings make up 48% of its $129M portfolio in Q4 2017.
  • Lau Associates opened 6 new positions and closed 4 in Q4 2017.
  • Lau Associates's portfolio value fell 0.2% quarter-over-quarter to $129M.

Based on Lau Associates's 13F filing for Q4 2017, filed 23 Jan 2018.